Funke-Kaiser H, Unger T
Hypertens Res. 2023; 46(11):2527-2534.
PMID: 37667044
DOI: 10.1038/s41440-023-01424-6.
Yamaguchi T, Morimoto S, Suda C, Ichihara A, Ishihara N, Nakamura S
Obes Facts. 2023; 16(4):335-343.
PMID: 37231878
PMC: 10427953.
DOI: 10.1159/000531076.
Yang T
Am J Physiol Renal Physiol. 2022; 323(5):F507-F514.
PMID: 36074917
PMC: 9602801.
DOI: 10.1152/ajprenal.00202.2022.
Gladysheva I, Sullivan R, Ramanathan K, Reed G
Biomedicines. 2022; 10(8).
PMID: 36009420
PMC: 9405551.
DOI: 10.3390/biomedicines10081874.
Yang T
Nephron. 2022; 147(3-4):234-243.
PMID: 35871512
PMC: 9867785.
DOI: 10.1159/000525635.
Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.
Lin H, Geurts F, Hassler L, Batlle D, Mirabito Colafella K, Denton K
Pharmacol Rev. 2022; 74(3):462-505.
PMID: 35710133
PMC: 9553117.
DOI: 10.1124/pharmrev.120.000236.
Soluble (Pro)renin Receptor Is Adversely Associated with Indices of Left Ventricular Structure and Function: The African-PREDICT Study.
Gafane-Matemane L, Kruger R, van Rooyen J, Gona P, Schutte A
J Cardiovasc Dev Dis. 2022; 9(5).
PMID: 35621841
PMC: 9144018.
DOI: 10.3390/jcdd9050130.
Role of (pro)renin receptor in cyclosporin A-induced nephropathy.
Hu J, Tan Y, Chen Y, Mo S, Hekking B, Su J
Am J Physiol Renal Physiol. 2022; 322(4):F437-F448.
PMID: 35073210
PMC: 9662808.
DOI: 10.1152/ajprenal.00332.2021.
Serum soluble (pro)renin receptor level as a prognostic factor in patients undergoing maintenance hemodialysis.
Amari Y, Morimoto S, Suda C, Iida T, Okuda H, Yurugi T
Sci Rep. 2021; 11(1):17402.
PMID: 34465835
PMC: 8408265.
DOI: 10.1038/s41598-021-96892-6.
Loss of Soluble (Pro)renin Receptor Attenuates Angiotensin-II Induced Hypertension and Renal Injury.
Ramkumar N, Stuart D, Peterson C, Hu C, Wheatley W, Cho J
Circ Res. 2021; 129(1):50-62.
PMID: 33890822
PMC: 8225587.
DOI: 10.1161/CIRCRESAHA.120.317532.
Soluble (pro)renin receptor induces endothelial dysfunction and hypertension in mice with diet-induced obesity via activation of angiotensin II type 1 receptor.
Fu Z, Wang F, Liu X, Hu J, Su J, Lu X
Clin Sci (Lond). 2021; 135(6):793-810.
PMID: 33625485
PMC: 9215112.
DOI: 10.1042/CS20201047.
Relationship between Soluble (pro)Renin Receptor and Renin Activity in Patients with Severe Heart Failure.
Ikeda Y, Tsutsui K, Yamada Y, Kato R, Muramatsu T, Senbonmatsu T
J Clin Med. 2020; 9(12).
PMID: 33352807
PMC: 7765833.
DOI: 10.3390/jcm9124110.
Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism.
Watanabe D, Morimoto S, Morishima N, Kato Y, Nagashima Y, Shibata N
Int J Endocrinol. 2020; 2020:9640103.
PMID: 33061968
PMC: 7539071.
DOI: 10.1155/2020/9640103.
Association between serum soluble (pro)renin receptor level and worsening of cardiac function in hemodialysis patients: A prospective observational study.
Amari Y, Morimoto S, Iida T, Takimoto H, Okuda H, Yurugi T
PLoS One. 2020; 15(5):e0233312.
PMID: 32469890
PMC: 7259770.
DOI: 10.1371/journal.pone.0233312.
Soluble (pro)renin receptor treats metabolic syndrome in mice with diet-induced obesity via interaction with PPARγ.
Wang F, Luo R, Zou C, Xie S, Peng K, Zhao L
JCI Insight. 2020; 5(7).
PMID: 32271168
PMC: 7205274.
DOI: 10.1172/jci.insight.128061.
The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers.
Wang J, Nishiyama A, Matsuyama M, Wang Z, Yuan Y
Cell Commun Signal. 2020; 18(1):39.
PMID: 32143717
PMC: 7060546.
DOI: 10.1186/s12964-020-0531-3.
Soluble Prorenin Receptor Increases Blood Pressure in High Fat-Fed Male Mice.
Gatineau E, Gong M, Yiannikouris F
Hypertension. 2019; 74(4):1014-1020.
PMID: 31378099
PMC: 6739191.
DOI: 10.1161/HYPERTENSIONAHA.119.12906.
The (pro)renin receptor in health and disease.
Ichihara A, Yatabe M
Nat Rev Nephrol. 2019; 15(11):693-712.
PMID: 31164719
DOI: 10.1038/s41581-019-0160-5.
Soluble (pro)renin receptor as a potential therapy for diabetes insipidus.
Yang K, Yang T, Symons J
Am J Physiol Renal Physiol. 2018; 315(5):F1416-F1421.
PMID: 30019932
PMC: 6293289.
DOI: 10.1152/ajprenal.00266.2018.
Elevated (Pro)renin Receptor Expression Contributes to Maintaining Aerobic Metabolism in Growth Hormone Deficiency.
Seki Y, Yatabe M, Suda C, Morimoto S, Ichihara A
J Endocr Soc. 2018; 2(3):252-265.
PMID: 29594258
PMC: 5836533.
DOI: 10.1210/js.2017-00447.
